Abstract
Steven R Levine speaks to Sarah Freeston, Commissioning Editor.Dr Steven R Levine is a tenured Professor of Neurology and Emergency Medicine and Vice Chairman of Neurology. He is also an Associate Dean for Clinical Research and Faculty Development. Dr Levine's Research interests are in cerebrovascular disease and stroke. He completed his undergraduate education and Neurology Residency at the University of Michigan, Medical School at the Medical College of Wisconsin (WI, USA) and Fellowship in Cerebrovascular Disease/Stroke at the Henry Ford Health Sciences Center/NIH Designated Center for Stroke Research (MI, USA). He was the Detroit area principal investigator for the NIH-funded National Institute of Neurological Diseases and Stroke rt-PA Stroke Trial that led to the US FDA approval of the first treatment for acute ischemic stroke - tissue plasminogen activator (tPA). Dr Levine's research has been continuously NIH funded for the past 23 years; active in acute and preventive stroke clinical trials. Current major areas of his research involve proteins (antibodies) in the blood that promote clotting that may be a new risk factor for predicting recurrent stroke - antiphospholipid antibodies; refining our understanding of the markers for risk and benefits from t-PA treatment for acute ischemic stroke; the application of telemedicine (real-time video-audio telecommunications) to stroke (`telestroke'); and stroke clinical trials. Dr Levine has been training stroke subspecialists (fellows) since 1988. He serves/served on the editorial boards of several peer-reviewed journals, including Neurology, Stroke and Clinical Neuropharmacology. He has served as a consultant for NIH, American Heart Association/American Stroke Association, National Stroke Association and the pharmaceutical industry. He also serves/served as the safety monitor/independent medical monitor for several NIH-funded clinical trials including IMS 3, FAST-MAG, CLEAR-ER and INSTINCT. Dr Levine is the overall principal investigator for the State University of New York (NY, USA) NeuroNEXT Clinical Site, and is also the principal investigator for a Hub and Spoke Network for Neurological Emergency Treatment Trials, an NIH National Institute of Neurological Diseases and Stroke-funded clinical trials network. He has been listed in several directories of honors, including Best Doctors in America, America's Top Doctors, Best Doctors in New York, Best Heart and Stroke Doctors, New York Super Doctors and US News and World Report Top Doctors. He has received several institutional teaching awards. Dr Levine is a Fellow of The American Academy of Neurology and the American Heart Association Stroke Council, and is an elected member of the American Neurological Association. He has published over 160 peer-reviewed articles, 50 invited contributions/reviews, 20 editorials, 50 book chapters and three books in the field of stroke.
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Access to resources
Recommend
